AKT1 and breast carcinoma: Data from animal models have shown that PA decreases the protein expression levels of activated mTOR, AKT, and phosphorylated P70S6K (p-P70S6K)—important factors in the mTOR signaling pathway—in mammary carcinomas (19, 20).